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Abstract 
Background The 5-year survival rate for patients with breast cancer is much higher than 
patients with other types of cancer. Due to this longer survival period, breast cancer patients also 
tend to have increased rates of lost to follow-up, when compared to other cancers. When a 
patient becomes lost, the occurrence of distant metastasis cannot be reliably ascertained, unless 
the patient had a breast cancer-specific (BC) death. The impact of lost patients on recurrence 
rates and disease-free survival (DFS) was explored in breast cancer patients seen at the City of 
Hope from 1997 to 2012. 
Methods Female breast cancer patients with a stage of 0, I, II, or III at diagnosis were 
included in these analyses (N=2,358). Of these patients 1,937 were deemed non-lost and 421 
were lost. Kaplan-Meier estimates for DFS were stratified by lost status. Cox proportional 
hazards models were built to adjust for multiple predictors such as age group at diagnosis, race, 
comorbidity score, final cancer stage at diagnosis, and lymphovascular invasion (LVI) status. BC 
death rates were compared between non-lost and lost patients using a chi-square test. Missed 
recurrences were estimated and recurrence rates were calculated. Patients were separated into 20 
groups based on propensity scores from a logistic regression model using categorical distance 
between the patient’s residence and the City of Hope, age group at diagnosis, final cancer stage 
at diagnosis, hormone receptor status, and her2/neu status to predict the probability of becoming 
lost. Lost patients were removed and replaced with simulated lost patients. Simulated lost 
patients were sampled with replacement from the non-lost patients within each group and then 
one year of information was removed from those patients. The new 5-year DFS rate was 
calculated. This process of simulating lost patients and recalculating the 5-year DFS was 
bootstrapped 1,000 times. 
Results The 5-year DFS rate was 84.6% for non-lost patients and 95.1% for lost patients. 
Adjusting for age, race, comorbidity score, stage, and LVI, the risk of death or recurrence is 
61.0% lower for lost patients compared to non-lost patients. The BC death rate was 8.2% for 
non-lost patients and 2.4% for lost patients. This difference in BC death rates may be due to 
delays in death information for lost patients. There were 66 observed missed recurrence and 42 
estimated unobserved missed recurrences. The observed recurrence rate was 7.1% and the 
estimated recurrence rate was 11.7%. The mean 5-year DFS rate for simulated lost patients was 
86.2%. 
Conclusion There are missing recurrences for both non-lost and lost patients, yielding a lower 
observed recurrence rate than estimated and inflated DFS rates. Lost patients lead to even more 
missing recurrence information, yielding larger differences in the observed rates and estimated 
rates. Researchers could mention the lost to follow-up rate and the possible effects on DFS to 
avoid misleading rates. 
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Introduction 
The 5-year survival rate for patients with breast cancer is much higher than patients with other 
types of cancer. Due to this longer survival period, breast cancer patients also tend to have 
increased rates of lost to follow-up, when compared to other cancers. When a patient becomes 
lost, the occurrence of distant metastasis cannot be reliably ascertained, unless the patient had a 
breast cancer-specific death. The impact of lost patients on recurrence rates and disease-free 
survival was explored in breast cancer patients seen at the City of Hope from 1997 to 2012. 
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Methods 
 
Description of Cohort 
Female breast cancer patients seen at the City of Hope from 1997 to 2012, with a stage of 0, I, II, 
or III at diagnosis were included in these analyses (N=2,358). Stage IV breast cancer patients 
were excluded due to metastases at diagnosis. This means that the cancer of stage IV patients had 
spread beyond the breasts and local lymph nodes; therefore there was no recurrence to be 
measured. Of the 2,358 breast cancer patients, 1,937 were deemed non-lost and 421 were lost. 
 
Description of Variables 
Patients were defined as lost if they had not been to a follow-up assessment for two or more 
years. A recurrence is considered to be metastases to a distant site. A breast specific death occurs 
when a patient’s cause of death was due to breast cancer.  
Lymphovascular invasion (LVI) occurs when cancer cells are present in blood vessels or 
lymphatic vessels. The presence of LVI indicates to doctors that treatment should most likely 
include chemotherapy or hormone therapy. Tumor grade is an assessment of the growth patterns 
and features of cell differentiation. Well-differentiated cells have a low tumor grade, meaning 
that the growth and spread of the cancer tends to be slower than undifferentiated cells (high 
grade). Hormone receptor status and her2/neu status are related to the likelihood of the patient 
responding to certain drug treatments.  
Stage was categorized as 0, I, II, or III for the final cancer stage at diagnosis. Age group was 
categorized as “pre-menopausal” for patients younger than 50, “post-menopausal” for patients 50 
to 70, and “elderly” for patients older than 70. Race was categorized into “White”, “Black”, 
“Hispanic”, “Asian”, and “Other”. Comorbidity score was categorized as “low” for a score of 0, 
“medium” for 1 to 2, and “high” for 3 to 6.  
Distance was calculated using the patients’ zip codes. Data from SAS® Maps Online was used to 
match the patients’ zip codes to corresponding latitudes and longitudes. Conversions of degrees 
to radians (Equation 1) and the Great Circle Distance Formula (Equation 2) were used to 
calculate the shortest distance in miles between the patients’ residences and the City of Hope 
(COH). Distance was categorized as “close” if the patient lived 0 to 50 miles away from the City 
of Hope, “medium” for 51 to 100 miles, “far” for 100 or more miles, and “foreign” for patients 
residing in foreign countries.  
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 Equation 1. Converting Degrees to Radians 
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 Equation 2. Great Circle Distance Formula 
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Statistical Methods 
Kaplan-Meier estimates for disease-free survival probabilities were stratified by lost status. Cox 
proportional hazards models were built to adjust for multiple predictors such as age, race, 
comorbidity score, stage, and LVI status. Controls that did not meet the proportional hazards 
assumption by the supremum test were included as strata variables. These included tumor grade, 
hormone receptor status, and her2/neu status. 
Breast cancer-specific death rates were compared between non-lost and lost patients using a chi-
square test. The number of breast cancer deaths was also compared to distant recurrence to 
ascertain the completeness of recurrence information. A “missed” distant recurrence is 
considered when a patient has a breast cancer-specific death, but there is no distant recurrence 
information in the patient chart. 
The number of missed distant recurrences was estimated; then the observed distant recurrence 
rate was compared to the estimated distant recurrence rate. The number of missed recurrences for 
patients that experience a breast cancer-specific death can be computed (B from Table 1), but 
this number is unknown for patients that did not experience a breast cancer-specific death. To 
estimate the number of missed recurrences for patients that without a breast cancer-specific 
death, an assumption that the ratio of missed recurrences is proportional to the ratio of observed 
recurrences was made. With this assumption, the number of missed recurrences for patients 
without a breast cancer-specific death was estimated, shown by Equation 3. 
The observed recurrence rate is the total number of observed recurrences divided by the total 
number of patients, shown in Equation 4. The estimated recurrence rate is the sum of the total 
number of observed recurrences, the number of observed missed recurrences, and the number of 
estimated missed recurrences, divided by the total number of patients, show in Equation 5. The 
difference between these two recurrence rates is the estimated percentage of missed recurrences. 
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Table 1. Distant Recurrence by Breast Cancer-Specific Death (Without Data) 
 No BC Death BC Death Total 
No Distant Recurrence A B A+B 
Distant Recurrence C D C+D 
Total A+C B+D N 
 
 
Equation 3. Estimating Missed Recurrences for Non Breast Cancer-Specific Death Patients 
             
 
 
 
 
Equation 4. Calculating Observed Recurrence Rate 
                         
   
 
 
 
Equation 5. Calculating Estimated Recurrence rate 
                           
      (  
 
 )
 
 
 
To model the impact of missing distant recurrences on disease-free survival, a logistic regression 
model was built to calculate propensity scores that determine which covariates predict becoming 
lost. Patients with similar propensity scores will have similar characteristics that might explain 
why they became lost.  
Propensity scores were then used to create 20 groups of similar size, such that patients in the 
same group have similar propensity scores, thus similar characteristics in terms of becoming lost. 
The proportion of lost patients per group was calculated and lost patients were removed. 
Sampling with replacement was then used to simulate the lost patients based on patients with 
complete information. These simulated patients were assigned a status of lost to see how this 
would impact the DFS rates. For actual lost patients, the median time from the date when a 
patient was first lost to the date of the last assessment is 12.025 months, which is approximately 
one assessment period. Therefore to simulate lost patients from non-lost patients, one assessment 
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period of known information was deleted from the last assessment period. By deleting one 
assessment period, there was a new censoring date for these simulated lost patients and any 
recurrence that occurred in that last assessment period became unknown.   
In the new cohort, 1,937 were non-lost and 421 were simulated lost. Kaplan-Meier estimates 
were recalculated for the 5-year disease-free survival probabilities. The 5-year disease-free 
survival probability for non-lost patients remained the same, as no changes were made to non-
lost patients; however the 5-year disease-free survival probability for simulated lost patients was 
not expected to be the same. To stabilize results, this process of resampling from the non-lost 
cohort, simulating lost patients, and recalculating the Kaplan-Meier estimate for 5-year disease-
free survival probability for simulated lost patients was bootstrapped 1,000 times. Each iteration 
of this process used the seed corresponding to that iteration for sampling (e.g. seed=1 for 1
st
 
iteration, seed=2 for 2
nd
 iteration, etc.). The mean 5-year disease-free survival probability for 
these 1,000 replications was calculated for the simulated lost patients and compared to the 
original 5-year disease-free survival probability for actual lost patients.                
All tests were two-sided and evaluated at the 0.05 significance level. All data management and 
analyses were performed in SAS
® 
9.3. Due to confidentiality, the breast cancer data from the 
City of Hope cannot be made publicly available.    
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Results 
 
Disease-free Survival 
Initially the entire cohort of 2, 358 patients was analyzed for disease-free survival stratified by 
lost status. Figure 1 indicates that non-lost patients tend to have significantly lower disease-free 
survival rates than lost patients (Log-rank P<0.01). The disease-free survival rates from Table 2 
also concurred with the notion that non-lost patients have lower disease-free survival rates (5-
year survival 84.6% for non-lost vs. 95.1% for lost). The log-rank chi-square test statistic of 
24.75 with 1 degree of freedom yields a p-value <0.01, which provides evidence that the survival 
functions for non-lost and lost patients are significantly different.     
 
Figure 1. Kaplan-Meier Curves for Disease-free Survival  
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Table 2. Kaplan-Meier Estimates for Disease-free Survival 
 Non-lost Lost 
1-Year 97.6% 98.1% 
3-Year 90.0% 96.8% 
5-Year 84.6% 95.1% 
10-Year 75.7% 86.3% 
Log-Rank Chi-Square=24.75                    DF=1                          P-value<0.01 
 
Table 2 shows the unadjusted 1, 3, 5, and 10-year disease-free survival rates by lost status. To 
adjust for covariates in the presence of lost status, Cox proportional hazards regression was used. 
Accounting for age at diagnosis, race, comorbidity score, stage, and LVI, the risk of death or 
distant recurrence is 61.0% lower for lost patients than non-lost patients (HR=0.39, P<0.01). 
Although race was an insignificant predictor, it remained in the model as a control, due to breast 
cancer incidence rates being different between races. From the Kaplan-Meier estimates (Table 2) 
and hazard ratio for disease-free survival (Table 3), it appears that lost patients have a 
significantly higher disease-free survival rate than non-lost patients, but this may likely be a 
result of missing recurrences. Distant recurrences are difficult to ascertain once a patient 
becomes lost, so the disease-free survival rate may be inflated, because these missing recurrences 
are not accounted for.   
 
Table 3. Adjusted Hazard Ratios for Disease-free Survival 
Variable (Reference) Level 
Adjusted 
Hazard Ratio 
95% CI  
Overall 
P-value 
Lost Status (Non-lost) Lost 0.39 (0.27, 0.57) <0.01 
Age (Post-Menopausal) 
Elderly 2.73 (1.99, 3.74) 
<0.01 
Pre-Menopausal 1.29 (0.98, 1.69) 
Race (White) 
Asian 0.83 (0.57, 1.20) 
0.80 
Black 1.13 (0.68, 1.90) 
Hispanic 1.03 (0.78, 1.36) 
Other 0.79 (0.25, 2.51) 
Comorbidity Score (Low) 
High 3.43 (2.10, 5.62) 
<0.01 
Medium 1.38 (1.03, 1.86) 
Stage (0) 
I 8.64 (2.79, 26.73) 
<0.01 II 12.90 (4.10, 40.65) 
III 31.33 (9.87, 99.51) 
*LVI Status (No) Yes 1.52 (1.16, 2.01) <0.01 
* 71 patients with unknown LVI status  
NOTE: Model is stratified on tumor grade, hormone receptor status, and her2/neu status.  
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Breast Cancer-Specific Death  
To account for missing recurrences, breast cancer-specific death rates were compared by lost 
status. Table 4 shows that, overall 7.1% of the cohort experienced a breast cancer-specific death 
and 92.9% did not. A chi-square test statistic of 17.47 with 1 degree of freedom yields a p-value 
<0.01, meaning that there appears to be a significant association between breast cancer-specific 
death and lost status. From Table 4, 8.2% of non-lost patients and 2.4% of lost patients 
experienced a breast cancer-specific death. The non-lost patients have a 5.8% higher breast 
cancer-specific death rate than lost patients. This may be due to the delay in death information 
for lost patients to the City of Hope. Death information for lost patients who died could be 
obtained through sources such as the National Death Index, but due to limited resources, it is not 
possible to search for the lost patients daily.  
 
Table 4. Breast Cancer-Specific Death by Lost Status 
Frequency 
Column Percent 
Non-Lost Lost Total 
No BC Death 
1779 
91.8% 
411 
97.6% 
2190 
92.9% 
BC Death 
158 
8.2% 
10 
2.4% 
168 
7.1% 
Total 1937 421 2358 
Chi-Square=17.47                             DF=1                              P-value<0.01 
 
Missed Distant Recurrences and Recurrence Rates 
Patients with a breast cancer-specific death must have had a distant metastatic site, so 
theoretically the number of patients that had a breast cancer-specific death, without distant 
recurrence should be 0. From Table 5, the number of patients that had a breast cancer-specific 
death, but did not have a distant recurrence is 66. This means that there are 66 missed 
recurrences in the cohort for patients who experienced a breast cancer-specific death. Of these 66 
observed missed recurrences, 60 occurred for non-lost patients and 6 for lost patients.   
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Table 5. Distant Recurrence by Breast Cancer-Specific Death 
 No BC Death BC Death Total 
No Distant Recurrence 2125 66 2191 
Distant Recurrence 65 102 167 
Total 2190 168 2358 
 
Equation 6 shows the calculation for the estimated number of missed recurrences for patients that 
did not experience a breast cancer-specific death, which was approximately 42 patients. Equation 
7 shows the calculation for the observed recurrence rate, which in this cohort was 7.1%. 
Equation 8 shows the calculation for the estimated recurrence rate, which was 11.7%.  From 
these calculations, there was an estimated 108 missed recurrences, which is approximately 4.6% 
of the entire cohort.  
 
Equation 6. Estimated Number of Missed Recurrences for Non Breast Cancer-Specific Death 
Patients 
              
  
   
       
 
Equation 7. Observed Recurrence Rate 
                         
   
    
              
 
Equation 8. Estimated Recurrence rate 
                           
            
    
              
 
 
 
 
13 
 
Disease-free Survival for Simulated Lost Patients 
A logistic regression model was built using distance, age, stage, hormone receptor status, and 
her2/neu status to predict the probability of being lost. As seen in Table 6, the predictors 
previously listed were all significantly associated with a patient’s lost status. There was a 
noticeable pattern for distance; patients residing further away from the City of Hope have higher  
odds of becoming lost, with the exception of foreign patients, but this may be due to the low 
number of foreign patients (n=4). There was a noticeable pattern for stage as well; patients with a 
higher stage of breast cancer have lower odds of becoming lost.  
 
Table 6. Associations for Becoming Lost Using Logistic Regression 
Variable (Reference) Level 
Adjusted 
Odds Ratio 
95% CI  
Overall 
P-value 
Distance (Close) 
Medium 1.08 (0.72, 1.64) 
<0.01 Far 2.60 (1.74, 3.90) 
Foreign 1.26 (0.12, 13.04) 
Age (Post-Menopausal) 
Elderly 1.53 (1.12, 2.09) 
0.03 
Pre-Menopausal 1.16 (0.91, 1.48) 
Stage (0) 
I 2.82 (1.81, 4.39) 
<0.01 II 2.65 (1.66, 4.22) 
III 1.79 (1.04, 3.09) 
*Hormone Receptor Status 
(Negative) 
Positive 1.36 (1.01, 1.83) <0.01 
**Her2/neu Status 
(Negative) 
High+ 1.08 (0.74, 1.58) 
<0.01 Low+ 1.12 (0.59, 2.13) 
Positive NOS 5.09 (1.88, 13.76) 
* 184 patients with unknown hormone receptor status 
** 678 patients with unknown her2/neu status 
 
The probabilities calculated from the logistic regression model were used as the propensity 
scores for grouping patients with similar characteristics in terms of becoming lost. The patients 
were sorted and separated into 20 groups, such that patients in the same group have similar 
propensity scores. Within each group, the frequencies of lost patients were saved and used for 
sampling. Table 7 shows the distribution of lost and non-lost patients within each group.  
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Table 7. Distribution of Lost and Non-lost Within the 20 Propensity Score Groups 
Group Lost Non-lost Total 
1 13 105 118 
2 9 109 118 
3 11 107 118 
4 16 102 118 
5 15 103 118 
6 16 102 118 
7 19 99 118 
8 8 110 118 
9 24 94 118 
10 15 103 118 
11 9 109 118 
12 13 105 118 
13 14 104 118 
14 18 100 118 
15 20 98 118 
16 27 91 118 
17 42 76 118 
18 40 78 118 
19 41 77 118 
20 51 65 116 
Total 421 1937 2358 
 
The lost patients were then removed, leaving only non-lost patients in the sampling cohort. 
Within each group, non-lost patients were sampled with replacement to simulate lost patients. By 
removing one assessment period (roughly one year) from those patients, they become simulated 
lost patients and the distant recurrences that took place in that year became unknown. Kaplan-
Meier estimates were recalculated for 5-year disease-free survival based on the new cohort. The 
process of resampling to simulate lost patients and estimating the 5-year disease-free survival 
rate was bootstrapped to stabilize results. From the 1,000 repetitions, the average 5-year disease-
free survival rate for simulated lost patients was 86.2%. Recall that the 5-year survival rate for 
the actual lost patients was 95.1%. This showed an 8.9% difference between the actual and 
simulated 5-year disease-free survival rates. Therefore the disease-free survival rates for lost 
patients appear to be inflated due to missing recurrence information.         
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Conclusion 
The initial Kaplan-Meier estimates for disease-free survival and adjusted hazard ratios suggest 
that lost patients have higher disease-free survival rates than non-lost patients, which may 
actually be due to the fact that they are lost, and their recurrence information is missing. From 
the known data, observed missed recurrences were calculated and used to estimate the 
unobserved missed recurrences. It seems reasonable to assume that due to the missed recurrences 
for both non-lost and lost patients, disease-free survival rates would be misleading. However, the 
number of missing recurrences for lost patients appears to be much higher, leading to even more 
distorted recurrence rates than in the non-lost population. The impact of losing patients was 
modeled and the 5-year disease-free survival rates also concurred with the notion that the 
disease-free survival rates for lost patients are inflated. 
The missing recurrences due to patients becoming lost to follow-up must be accounted for to 
accurately estimate disease-free survival. One solution would be for hospitals to track down lost 
patients and collect the appropriate information, but this is not very plausible due to limited 
resources. A more realistic solution would be for researchers to mention this caveat when 
presenting disease-free survival analyses. The researchers could provide descriptive statistics 
about the lost to follow-up rate in the cohort and mention the possible effects of lost to follow-up 
on disease-free survival.        
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Limitations and Future Studies 
There were limitations in this study due to time constraints. The proportional hazard assumption 
was not met for lost status, tumor grade, hormone receptor status, and her2/neu status for the Cox 
proportional hazards model. The control variables tumor grade, hormone receptor status and 
her2/neu status were accounted for by stratifying on those variables in the model. However, lost 
status was the main variable of interest. In order to obtain a hazard ratio for comparison, lost 
status could not be included as a strata variable. One method for accounting for lost status being 
time dependent would be to include it as an interaction term with time, or more commonly the 
natural log of time. Another solution would be to include lost as a time dependent covariate in 
the model. 
There were a few more analyses that could also be explored in the future. The propensity score 
analysis computed the 5-year disease-free survival probabilities after resampling. In order to 
account for other factors, a Cox proportional hazards model could also be bootstrapped in a 
similar way, yielding hazard ratios for exploration.  
The definition of lost in this study was a patient not going to a follow-up visit for two or more 
years, so originally two assessment periods were supposed to be deleted. In this analysis, only 
one assessment period was deleted, due to the median time between the date when a patient was 
first lost and the date of their last assessment period being approximately one assessment period. 
Going forward the removal of two assessment periods could also be explored.       
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Appendix  
 
SAS Code Data Management  
 
 
options rightmargin=1in   
  leftmargin=1in 
  topmargin=1in 
  bottommargin=1in 
  nodate nonumber ls=85 center   
  FORMDLIM="-";    
 
 
 
libname raw "D:\Senior Project\Data\Raw"; 
libname derived "D:\Senior Project\Data\Derived"; 
libname zip "D:\Senior Project\Zip"; 
libname sassy "D:\Senior Project\Sassy"; 
libname newfmt "D:\Senior Project\Data\New Formats"; 
 
 
*** Laptop SAS9.2 is 32bit; 
Options fmtsearch=(raw.formats derived.formats); 
 
*** Campus CPU SAS9.3 is 64bit; 
*Options fmtsearch=(newfmt.formats); 
 
 
 
 
 
 
data bca1; 
 
 merge raw.diagnosis derived.clinical_characteristics(IN=clinical); 
 by pid dxid; 
 
 if clinical=1; 
 
run; 
 
 
 
 
 
data bca2; 
 
 merge bca1(IN=clinical) derived.patient_characteristics; 
 by pid dxid; 
 
 if clinical=1;   
 
*** only use patients in clinical_characteristics data set; 
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  **** recode LTFU, missing is non-lost and 1&2 are lost; 
 
 if lostflag=1 then lost=1; 
  else lost=0; 
 
 
 
 
  *** years between diagnosis and event/censor date; 
   
 years = (osdt-dxdt)/365.25;  
 
 
 
 
 
 length insur $10. comorbid $10. race $15. HR_grp $10. Her2neu_grp $15.  
   age_grp $10.; 
 
 
 
 
   *** create age groups pre-meno, post-meno, & elderly; 
 
 if agedx < 50 then age_grp="Pre-Meno"; 
  else if 50 <= agedx <= 70 then age_grp="Post-Meno"; 
  else if agedx >70 then age_grp="Elderly"; 
 
 
 
 
 if stage_final=22 then stage=0; 
  else if stage_final=23 | stage_final=23.1 | stage_final=23.2 then 
 stage=1; 
  else if stage_final=23.5 | stage_final=24 | stage_final=25 then 
 stage=2; 
  else if stage_final=25.5 | stage_final=26 | stage_final=27 |  
   stage_final=27.5 then stage=3; 
   
 
 if stage=. then delete; 
 
 
 
 
 
 if race_eth=1 then race="White"; 
  else if race_eth=3 then race="Black"; 
  else if race_eth=5 then race="Asian"; 
  else if race_eth=7 | race_eth=9 | race_eth=10 then race="Other"; 
  else race="Hispanic"; 
 
 
 
 
20 
 
 if comorbidity=0 then comorbid="Low"; 
  else if comorbidity=1 | comorbidity=2 then comorbid="Med"; 
  else comorbid="High"; 
 
 
 
 if insurance=1 then insur="Managed"; 
  else if insurance=5 | insurance=5.5 | insurance=5.75 then  
   insur="Medicare"; 
  else if insurance=4 then insur="Medicaid"; 
  else if insurance=0 | insurance=2 | insurance=6 then  
   insur="Other"; 
  else if insurance=-1 | insurance=. then insur="Unknown"; 
 
 
 
 if HR=0 then HR_grp="Negative"; 
  else if HR=1 then HR_grp="Positive"; 
  else HR_grp="Unknown"; 
 
 
 
 if her2neu=1 then Her2neu_grp="Negative"; 
  else if her2neu=2 then Her2neu_grp="Low +"; 
  else if her2neu=3 then Her2neu_grp="High +"; 
  else if her2neu=4 then Her2neu_grp="Positive NOS"; 
  else Her2neu_grp="Unknown"; 
 
 
 
run; 
 
 
 
 
data bca3; 
 
 merge bca2(IN=clinical) raw.metastatic_sites; 
 by pid dxid; 
 
 
 if clinical=1;    
 
*** only use patients in clinical_characteristics data set; 
  
if first.pid=1; 
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/* distant met: intra-ab 5, bone 6, lung 7, pleural effusion 8, pericardial 
effusion 9,liver 10, bone marrow 11, brain/cns 12, LN other distant 15,  
LN other distant visceral 17, LN other distant non-visceral 18, skin 20, 
contralateral breast 14, Contralateral supraclavicular nodes 19, Ipsilateral 
supraclavicular nodes 16 ONLY IF DIAGNOSED AFTER JAN 01, 2003 
 
Meninges 13 but deactivated & changed to brain/cns 12                      */ 
 
 
 
if site=5 | site=6 | site=7 | site=8 | site=9 | site=10 | site=11  
| site=12 | site=15 | site=17 | site=18 | site=20 | site=14 then 
met=1; 
   else if site=16 & sitedt >= '01jan2003'd then met=1; 
   else if site=19 & sitedt >= '01jan2003'd then met=1; 
   else met=0; 
 
 
 
 
*** evt = new event variable for death/recurrence; 
 
 if met=1 | event=1 then evt=1;   
  else evt=0; 
 
 
 
 
  ***** censordt = date of first met/event/censor; 
  
 if sitedt=. then cendt=osdt; 
  else if osdt <= sitedt then cendt = osdt; 
  else if sitedt < osdt then cendt= sitedt; 
 
  format cendt DATE9.; 
 
  
censordt=(cendt-dxdt)/365.25; 
 
run 
 
 
 
 
 
 
 
data bca4; 
 
 merge raw.demographics bca3(IN=clinical); 
 by pid; 
 
 
 if clinical=1; 
 
 
 if deathicd=" " then dead=0; 
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  else dead=1; 
 
 
 
   /* ICD codes for breast specific death 174, C50, 233 */ 
 
 if substr(deathicd, 1, 3)= "174" | substr(deathicd, 1, 3)= "C50" |  
  substr(deathicd, 1, 3)= "233" then breastdeath=1; 
  else breastdeath=0; 
 
 
 
 
 
run; 
 
 
 
 
 
 
 
data bca5; 
 
 merge bca4(IN=clinical) raw.study_accession; 
 by pid; 
 
 if clinical=1; 
 
 zipcode=zip; ****** rename zip for merging later; 
 
 
 
  ******* education status ******; 
 
 if edustat=0 | edustat=1 | edustat=2 then edu="Other/Less than HS 
Grad"; 
  else if edustat=3 then edu="HS Grad"; 
  else if edustat=4 | edustat=5 then edu="AA/Tech"; 
  else if edustat=6 | edustat=7 then edu="College Grad"; 
  else edu="Unknown"; 
 
 
 
  ******* Employment status at diagnosis; 
 
 if empstatdx=1 | empstatdx=2 | empstatdx=3 | empstatdx=4 | empstatdx=5  
then employ="Employed/Student"; 
  else if empstatdx=9 then employ="Unemployed"; 
  else employ="Other"; 
 
  **** Other: homemaker, medical leave, retired, disabled; 
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  *** BMI = weight(in KG)/(height*height(in M)); 
  *** height in CM & weight in KG; 
  
 if heightpres=-1 | weightpres=-1 then BMI="Unknown"; 
  else BMI =  weightpres / (0.01*heightpres*0.01*heightpres); 
 
 
 length BMI_grp $15.; 
 
  
if BMI="Unknown" then BMI_grp="Unknown"; 
  else if 0 <= BMI < 18.5 then BMI_grp="Underweight"; 
  else if 18.5 <= BMI < 25 then BMI_grp="Normal"; 
  else if 25 <= BMI < 30 then BMI_grp="Overweight"; 
  else if BMI >= 30 then BMI_grp="Obese"; 
 
 
 
run; 
 
 
 
 
 
 
 
data bca6; 
 
 merge bca5(IN=clinical) raw.breast_diagnosis; 
 by pid dxid tumorid; 
 
 if clinical=1; 
 
 
run; 
 
 
 
 
data bca7; 
 
 merge bca6(IN=clinical) raw.solid_tumor_stage; 
 by pid dxid tumorid; 
 
 if clinical=1; 
 
 length grade_grp $15. LVI_grp $10; 
 
 
 
 if stage=0 then grade=put(dcishistogrd, 8.); 
else if stage=1 | stage=2 | stage=3 then grade=put(invcahistogrd, 
8.); 
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 if grade=1 then grade_grp="Low"; 
  else if grade=2 then grade_grp="Intermediate"; 
  else if grade=3 then grade_grp="High"; 
  else grade_grp="Unknown"; 
 
 
 
 LVI=lymphvascinv; 
 
 if LVI=0 then LVI_grp="No"; 
  else if LVI=1 then LVI_grp="Yes"; 
  else LVI_grp="Unknown"; 
 
 
run; 
 
 
 
 
proc sort data=bca7; 
 by zipcode; 
run; 
 
 
 
 
 
******** zip codes from SAS Maps Online to create distance variable ********; 
 
  ***** Imports and outputs zipcode SAS datasets ****; 
 
proc cimport infile="C:\Users\Debbie\Documents\Senior  
Project\Zip\zipcode_Jan13_v9.cpt" 
 lib=zip;  
run; 
 
 
  *** Put 2 zipcode data sets together; 
 
proc append base=zip.Zip1 data=zip.Zip2; 
run; 
 
  ****** Final zip code data set = zip.zipcode *************; 
 
proc sort data=zip.Zip1 out=zip.zipcode;  
 by zip zip_class;  
run; 
 
  ******** recreate the index ******; 
 
proc datasets lib=zip; 
 modify zipcode; 
 index create zip; 
run; 
 
 
 
25 
 
 
 
 
  **** X = longitude in degrees & Y = latitude in degrees; 
  *** COH NCCN zip = 91010, lat=34.1357  long=-117.9655; 
 
 
data zipp; 
 set zip.zipcode; 
 zipcode = put(zip, 5.);   
 
*** convert zipcode to character to match zipcode in BCA data set; 
  
drop zip; 
 rename zipcode=zip; 
  
run; 
 
 
 
 
 
data sassy.final; 
 merge bca7(IN=clinical) zipp; 
 by zip; 
 
 if clinical=1; 
 
   
   *** Convert long & lat from degrees to radians; 
 
 COH_long = atan(1)/45 * -117.9655; 
 COH_lat = atan(1)/45 * 34.1357;  
 
 long = atan(1)/45 * X; 
 lat = atan(1)/45 * Y; 
 
 
   *** dist in miles; 
             
   *** Great Circle Distance Formula; 
 dist = 3949.99 * arcos(sin(lat) * sin(COH_lat) +  
   cos(lat) * cos(COH_lat) * cos(long - COH_long)); 
 
 
  
 Length dist_grp $8.; 
 
 if 0 < dist <= 50 then dist_grp="Close"; 
  else if 50 < dist <= 100 then dist_grp="Medium"; 
  else if 100 < dist then dist_grp="Far"; 
  else if zip=0 | zip=1 | zip=2 then dist_grp="Foreign"; 
  else dist_grp="Unknown"; 
 
 
 
run; 
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******** transporting formats from 32bit SAS to 64bit SAS **************; 
 
 
 
*** In 32bit ***; 
 
filename rawfmt 'D:\Senior Project\Data\New Formats\rawformats.cpt';  /* 
transport file you are creating */ 
filename derfmt 'D:\Senior Project\Data\New Formats\derivedformats.cpt';   
 
proc cport lib=raw file=rawfmt memtype=catalog; 
   select formats; 
run; 
 
proc cport lib=derived file=derfmt memtype=catalog; 
   select formats; 
run; 
 
 
 
**** In 64bit ***; 
 
filename rawfmt 'F:\Senior Project\Data\New Formats\rawformats.cpt';   /* 
same as in Step 1 above */ 
filename derfmt 'F:\Senior Project\Data\New Formats\derivedformats.cpt';   
 
proc cimport infile=rawfmt lib=newfmt; 
run; 
 
proc cimport infile=derfmt lib=newfmt; 
run; 
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SAS Code for Analyses 
 
 
options rightmargin=1in   
  leftmargin=1in 
  topmargin=1in 
  bottommargin=1in 
  nodate nonumber ls=85 center   
  FORMDLIM="-";    
 
 
 
 
 
libname raw "F:\Senior Project\Data\Raw"; 
libname derived "F:\Senior Project\Data\Derived"; 
libname zip "F:\Senior Project\Zip"; 
libname sassy "F:\Senior Project\Sassy"; 
libname newfmt "F:\Senior Project\Data\New Formats"; 
 
 
 
 
*** Laptop SAS9.2 is 32bit; 
*Options fmtsearch=(raw.formats derived.formats); 
 
*** Campus CPU SAS9.3 is 64bit; 
Options fmtsearch=(newfmt.formats); 
 
ods html close; 
ods listing; 
 
 
ods graphics on; 
ods listing sge=on; 
 
 
 
 
****************************************************************************; 
 
 
 ********* Survival from death: Non-lost vs Lost ************; 
 
  **** p-value<0.0001; 
 
proc lifetest data=sassy.final plot=survival METHOD=KM;   
 
*** product-limit is the same as Kaplan-Meier; 
 
 time years*event(0); 
 strata lost / test=logrank; 
 title "KM Survival Estimates for Death by Lost Status"; 
run; 
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 *** lost p-value<0.0001; 
 
 
proc phreg data=sassy.final; 
 class lost(ref="0");  
 model years*event(0) = lost ;   
 title "Cox Regression for Risk of Death"; 
run; 
 
 
 
 
***************** stratify on GRADE, HR, Her2neu  ************************; 
 
  ****** Lost p-value<0.0001; 
 
 
 
proc phreg data=sassy.final; 
 
 title "Cox Regression for Risk of Death"; 
 
 class lost(ref="0") age_grp(ref="Post-Meno") race(ref="White")  
   comorbid(ref="Low") stage(ref="0") grade_grp(ref="Low")  
HR_grp(ref="Negative") Her2neu_grp(ref="Negative")  
LVI_grp(ref="No");  
 
 model years*event(0) = lost age_grp race comorbid stage LVI_grp;  
  
 strata grade_grp HR_grp Her2neu_grp; 
 
 assess ph / resample;  
 
 
run; 
 
 
 
 
 
********************************* DFS **************************************; 
 
 
 
*** Survival from death and breast cancer recurrence: Non-lost vs Lost ****; 
 
 
   
  *** p-value<0.0001; 
 
 
proc lifetest data=sassy.final plot=survival (atrisk=0 to 15 by 2.5 CB=HW  
test nocensor) METHOD=KM;   
 
*** product-limit is the same as Kaplan-Meier; 
 
 time censordt*evt(0); 
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 strata lost / test=logrank;  
 label censordt="Years"; 
 title "KM Estimates for DFS by Lost Status"; 
run;  *** p-value<0.0001; 
 
proc phreg data=sassy.final; 
 class lost(ref="0");  
 model censordt*evt(0) = lost;   
 title "Cox Regression for Risk of Death and Breast Cancer Recurrence"; 
run; 
 
 
 
 
 
********************** stratafy on GRADE, HR, Her2neu  ********************; 
 
 ** lost p-value<0.0001; 
 
proc phreg data=sassy.final; 
  
 title "Cox Regression for Risk of Death and Breast Cancer Recurrence"; 
  
 class lost(ref="0") age_grp(ref="Post-Meno") race(ref="White")  
   comorbid(ref="Low") stage(ref="0") grade_grp(ref="Low")  
HR_grp(ref="Negative") Her2neu_grp(ref="Negative") 
LVI_grp(ref="No");  
 
 strata grade_grp HR_grp Her2neu_grp; 
 
 model censordt*evt(0) = lost age_grp race comorbid stage LVI_grp;  
 
 
 hazardratio lost / CL=WALD DIFF=REF; 
 hazardratio age_grp / CL=WALD DIFF=REF; 
 hazardratio race / CL=WALD DIFF=REF; 
 hazardratio comorbid / CL=WALD DIFF=REF; 
 hazardratio stage / CL=WALD DIFF=REF; 
 hazardratio LVI_grp / CL=WALD DIFF=REF; 
 
 assess ph / resample; 
 
run; 
 
 
 
 
 
****************************************************************************; 
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************ Method 1 - Breast Specific Survival: Lost vs Non-lost *********; 
 
 
 
proc freq data=sassy.final; 
 table breastdeath*lost / chisq; 
run; 
 
 /* chisq=17.4705 , p-value<0.0001 */ 
 
 
 
 
 
 
********** Method 2 - Estimate Number of Missed Recurrences *************; 
 
 
 
  /* 66 missed recurrences */ 
 
proc freq data=sassy.final; 
 title "Two-way Table: Dist Met x Breast Death"; 
 tables met*breastdeath; 
run; 
 
 
 
proc freq data=sassy.final; 
 title "66 Missed Recurrences - 6 lost & 60 non-lost"; 
 where met=0 and breastdeath=1; 
 table lost / chisq; 
run; 
 
 
 
proc freq data=sassy.final; 
 title "Death Status for 66 non-BCA Deaths with Dist Mets"; 
 where breastdeath=0 & met=1; 
 table dead;  
run; 
 
 
proc freq data=sassy.final; 
 title "Two-way Table: Lost by Dist Met"; 
 table met*lost / chisq; 
run; 
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*************** Method 3 - Propensity Scores for LTFU on DFS **************; 
 
 
 
 
proc logistic data=sassy.final descending; 
  
 title "Logistic Regression for Lost Propensity Scores"; 
 
 
 class dist_grp(ref="Close") age_grp(ref="Post-Meno") race(ref="White")  
   edu(ref="College Grad") employ(ref="Unemployed")  
insur(ref="Managed") 
comorbid(ref="Low") stage(ref="0") grade_grp(ref="Low") 
HR_grp(ref="Negative") Her2neu_grp(ref="Negative") 
LVI_grp(ref="No") / param=ref; 
 
 
 model lost = dist_grp age_grp stage HR_grp Her2neu_grp / lackfit;  
 
  *** lack fit = Hosmer Lemeshow test; 
  
 
 score out=sassy.scores; 
run; 
 
 
 
 
 
 
 
*********** Simulating Lost Patients FOR METHOD 3 ********************; 
 
 
 
   *** group by propensity scores; 
 
proc sort data=sassy.scores; 
by P_1; 
run; 
 
 
 
data sassy.bucket; 
 set sassy.scores; 
 
 total = 2358; 
 
 size = round(total/20); 
 
 if 1 <= _N_ <= size then bucket=1; 
  else do i= 2 to 20; 
   if size*(i-1) < _N_ <= i*size then bucket=i; 
  end; 
 
run;  
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  *** save frequencies/proportions of lost; 
 
proc freq data=sassy.bucket; 
 table lost*bucket / nopercent norow nocol out=dist; 
run; 
 
 
 
data sassy.dist; 
 set dist; 
 if lost=1; 
run; 
 
 
 
 
 
  *** non-lost cohort; 
 
 
data sassy.nonlost;    *** includes alllllll variables; 
 merge sassy.dist sassy.bucket; 
 by bucket; 
 
 if lost=0;     *** non-lost only n=1684; 
 
 _NSIZE_=count;   *** _NSIZE_ needed for proc surverselect; 
      
run; 
 
 
 
 
 
 
proc sort data=sassy.nonlost; 
 by pid; 
run; 
 
 
proc sort data=raw.Continuous_Status; 
 by pid descending assessid; 
run; 
 
 
 
 
 
 
data sassy.constat; 
 merge sassy.nonlost(IN=non) raw.Continuous_Status; 
 by pid; 
 
 if non=1;   *** get assessid info for nonlost patients; 
 
run; 
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*** to get all the assessid's for deleting follow-ups; 
 
 
data sassy.total_constat;      
 set raw.Continuous_status; 
 pidnum=1; 
run; 
 
 
%macro repeats(mydset, mypidnum); 
 
 data &mydset; 
  set raw.Continuous_status; 
  pidnum=&mypidnum; 
 run; 
 
 
 proc append base=sassy.total_constat data=&mydset; run; 
 
%mend; 
 
 
%repeats(temp_constat2, 2); 
%repeats(temp_constat3, 3); 
%repeats(temp_constat4, 4); 
%repeats(temp_constat5, 5); 
%repeats(temp_constat6, 6); 
%repeats(temp_constat7, 7); 
%repeats(temp_constat8, 8); 
%repeats(temp_constat9, 9); 
%repeats(temp_constat10, 10); 
 
 
 
proc sort data=sassy.total_constat; 
 by pid pidnum descending assessid; 
run; 
 
 
 
 
 
data sassy.nonlost_population; 
 set sassy.constat; 
 by pid descending assessid; 
 
 if first.pid=1 & first.assessid=1;   
 
*** to get last assessment period; 
 
 lastassess=assessid; 
run; 
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proc sort data=sassy.nonlost_population; 
 by bucket pid; 
run;  
 
 
/* sampling from each bucket the number of lost patients we removed to get 
back original sample size but with only non-lost patients*/ 
 
 
 
proc surveyselect data=sassy.nonlost_population 
 method=URS seed=1 sampsize=sassy.nonlost_population outhits out=sample; 
 
 strata bucket; 
 
 title "Sampling With Replacement From Non-lost Patients: Sample"; 
    
run; 
 
 
/* URS=unrestricted random sampling = equal prob with replacement 
 
sampsize= give dataset with _NSIZE_ variable, which is the number  
we want to sample for each bucket 
 
outhits = outputs all obs, so replicates all get outputted            */ 
 
 
 
 
 
 
 
data sample; *** Simulated lost patients; 
 set sample; 
 lost=1;  
run; 
 
 
 
proc append base=sassy.nonlost_population data=sample force;   
run; 
  *** now constat2 is data set with all non-lost patients (2358); 
 
 
proc sort data=sassy.nonlost_population; 
 by pid; 
run; 
 
 
 
 
data sassy.simulated; 
 set sassy.nonlost_population; 
 by pid; 
 
   *** to handle repeat pid for resampled patients; 
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 if pid=lag(pid) then pidnum+1; 
  else if pid^=lag(pid) then pidnum=1; 
 
run; 
 
 
 
 
 
 
proc freq data=derived.patient_characteristics; 
table race_eth;run; 
 
 
 
 
data sassy.ID; 
 merge sassy.total_constat sassy.simulated; 
 by pid pidnum descending assessid; 
 
 retain prevlost prevpid prevpidnum; 
 
 
 
 if _N_=1 then do; 
  prevlost=lost; 
  prevpid=pid; 
  prevpidnum=pidnum; 
  newid=1; 
 end; 
 
        *** to fix "missing" lost; 
 
 
 
 if pid=prevpid & pidnum=prevpidnum & lost^=. then prevlost=lost; 
 
  else if pid=prevpid & pidnum=prevpidnum & lost=. then  
lost=prevlost; 
 
  else if pid=prevpid & pidnum^=prevpidnum & lost^=. then do; 
    prevlost=lost; 
    prevpid=pid; 
    prevpidnum=pidnum; 
    newid+1; 
   end; 
 
  else if pid=prevpid & pidnum^=prevpidnum & lost=. then delete; 
 
  else if pid^=prevpid then do; 
    if lost=. then delete; 
     else do; 
      prevlost=lost; 
      prevpid=pid; 
      prevpidnum=pidnum; 
      newid+1; 
     end; 
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   end; 
 
 
run; 
 
 
 
 
 
 
proc sort data=sassy.ID; 
 by newid assessid; 
run; 
 
 
 
 
 
proc transpose data=sassy.ID out=sassy.trans; 
 by newid; 
 var assessid; 
run; 
 
 
 
 
 
 
data sassy.DFS; 
 merge sassy.ID sassy.trans; 
 by newid; 
 
 lastassess=largest(2, OF COL1-COL17);    
 
*** k=2 to go back 1 assessment period, change k for going back more periods;  
 
 
    
 if last.newid=1; 
*** new date of first met/event/censor for simulated patients; 
 
*** last assessment date is censordt, if 1st met beyond last assess date then 
no met; 
 
 
 newmet=met; 
 newcensordt=censordt; 
 
 
 if lost=1 then do; 
 
 
  if vitalstatdt^=. then lostdt=(vitalstatdt-dxdt)/365.25; 
   *** simulated lost date; 
 
   else if vitalstatdt=. then lostdt=(quality_fudt- 
dxdt)/365.25; 
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   if lostdt<0 then lostdt=(quality_fudt-dxdt)/365.25;   
 
*** for pid 256570 error bc vitalstatdt is before dxdt; 
 
 
  if met=1 & lostdt <= censordt then do; 
 
newmet=0;  
 
   *** Met is unknown after lost date; 
 
 
   newcensordt=lostdt;       
   
  end; 
 
 
  if event=0 & lostdt <= osdt then newcensordt=lostdt;   
 
  *** For no death, lost date is new censor date; 
    
 end; 
 
 
 
 
 if newmet=1 | event=1 then newevt=1;   
 
*** newevt = new event variable for death/recurrence; 
 
  else newevt=0; 
 
 
 
 keep newid pid pidnum lost newevt newcensordt; 
run; 
 
proc lifetest data=sassy.DFS noprint outsurv=surv;   
*** product-limit is the same as Kaplan-Meier; 
 time newcensordt*newevt(0);        
 strata lost / test=logrank; 
 label newcensordt="Years"; 
 title "KM Estimates of DFS by Lost Status: SIMULATED Lost Patients"; 
run; 
  
 
 
 
data sassy.SIMULATED_Survival; 
 set surv; 
 by lost newcensordt; 
 
 if newcensordt >= 5 & Survival^=. then output; 
    
run; 
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data sassy.SIMULATED_Surv5Yr; 
 set sassy.SIMULATED_Survival; 
 by lost; 
 
 if lost=1; 
 
 if first.lost=1; 
 
 keep lost newcensordt survival; 
run; 
 
 
 
 
 
 
 
*************** start macro ; 
 
 
%macro DFS(n); 
 
 
 %do i=2 %to &n; 
 
   
 /* to reset sassy.nonlost_population because of appending */ 
 
  data sassy.nonlost_population; 
   set sassy.constat; 
   by pid descending assessid; 
 
   if first.pid=1 & first.assessid=1;   
 
 /* to get last assessment period */ 
   lastassess=assessid; 
 
  run; 
 
 
 
 
  proc sort data=sassy.nonlost_population; 
   by bucket pid; 
  run;  
 
 
/* sampling from each bucket the number of lost patients we removed  
   to get back orginal sample size but with only non-lost patients */ 
 
 
 
  proc surveyselect data=sassy.nonlost_population 
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   method=URS seed=&i sampsize=sassy.nonlost_population  
outhits out=sample&i; 
 
   strata bucket; 
 
title "Sampling With Replacement From Non-lost  
Patients: Sample&i"; 
    
  run; 
 
 
/* URS=unrestricted random sampling = equal prob with replacement 
 
sampsize= give dataset with _NSIZE_ variable, which is the number  
we want to sample for each bucket 
 
outhits = outputs all obs, so replicates all get outputted          */ 
 
 
 
 
 
 
  data sample_&i;   /* Simulated lost patients */ 
   set sample&i; 
   lost=1;  
  run; 
 
 
 
  proc append base=sassy.nonlost_population data=sample_&i force; 
  
  run; 
     
 /* now constat2 is data set with all non-lost patients (2358) */ 
 
 
  proc sort data=sassy.nonlost_population; 
   by pid; 
  run; 
 
 
 
 
  data Simulated&i; 
   set sassy.nonlost_population; 
   by pid; 
 
    /* to handle repeat pid for resampled patients */ 
 
   if pid=lag(pid) then pidnum+1; 
    else if pid^=lag(pid) then pidnum=1; 
 
  run; 
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  data ID&i; 
   merge sassy.total_constat Simulated&i; 
   by pid pidnum descending assessid; 
 
   retain prevlost prevpid prevpidnum; 
 
 
 
   if _N_=1 then do; 
    prevlost=lost; 
    prevpid=pid; 
    prevpidnum=pidnum; 
    newid=1; 
   end; 
 
       /* to fix "missing" lost */ 
 
 
 
   if pid=prevpid & pidnum=prevpidnum & lost^=. then  
prevlost=lost; 
 
    else if pid=prevpid & pidnum=prevpidnum & lost=. then  
lost=prevlost; 
 
    else if pid=prevpid & pidnum^=prevpidnum & lost^=.  
then do; 
 
      prevlost=lost; 
      prevpid=pid; 
      prevpidnum=pidnum; 
      newid+1; 
     end; 
 
 
    else if pid=prevpid & pidnum^=prevpidnum & lost=.  
then delete; 
 
    else if pid^=prevpid then do; 
      if lost=. then delete; 
       else do; 
        prevlost=lost; 
        prevpid=pid; 
        prevpidnum=pidnum; 
        newid+1; 
       end; 
     end; 
 
 
  run; 
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  proc sort data=ID&i; 
   by newid assessid; 
  run; 
 
 
 
  proc transpose data=ID&i out=trans&i; 
   by newid; 
   var assessid; 
  run; 
 
 
 
 
  data DFS&i;     
 
 /* all nonlost pateints (Simulated lost patients) */ 
 
   merge ID&i trans&i; 
   by newid; 
 
   lastassess=largest(2, OF COL1-COL17);   
 
*** k=2 to go back 1 assessment period, change k for going back more periods;  
 
 
     
   if last.newid=1; 
 
 
 
 
 
 
/* new date of first met/event/censor for Simulated patients last assessment 
date is censordt, if 1st met beyond last assess date then no met */ 
 
 
   newmet=met; 
   newcensordt=censordt; 
 
 
   if lost=1 then do; 
 
 
    if vitalstatdt^=. then lostdt=(vitalstatdt- 
     dxdt)/365.25; 
     
/* Simulated lost date */ 
 
    else if vitalstatdt=. then lostdt=(quality_fudt- 
dxdt)/365.25; 
 
     if lostdt<0 then lostdt=(quality_fudt- 
      dxdt)/365.25; 
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/* for pid 256570 error bc vitalstatdt is before dxdt*/ 
 
 
    if met=1 & lostdt <= censordt then do; 
     newmet=0; 
 
    /* Met is unknown after lost date */ 
 
 
     newcensordt=lostdt;     
     
    end; 
 
 
    if event=0 & lostdt <= osdt then newcensordt=lostdt;  
 
   /* No death, lost date is new censor date */ 
    
   end; 
 
 
 
   if newmet=1 | event=1 then newevt=1; 
   
/* newevt = new event variable for death/recurrence */ 
    else newevt=0; 
 
    
   keep newid pid pidnum lost newevt newcensordt; 
 
 
  run; 
 
    
 
 
 
 
     
  proc lifetest data=DFS&i noprint outsurv=surv&i;   
/* product-limit is the same as Kaplan-Meier */ 
 
   time newcensordt*newevt(0);       
   strata lost / test=logrank; 
   label newcensordt="Years"; 
   title "KM Estimates of DFS by Lost Status: SIMULATED Lost  
Patients from Sample&i"; 
  run; 
  
 
 
 
  data SIMULATED_Survival&i; 
   set surv&i; 
   by lost newcensordt; 
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   if newcensordt >= 5 & Survival^=. then output; 
    
  run; 
 
 
  data SIMULATED_Surv5Yr&i; 
   set SIMULATED_Survival&i; 
   by lost; 
 
 
   if lost=1;      
 
/* only care about lost because nonlost doesn't have any changes */ 
 
   if first.lost=1; 
 
   keep lost newcensordt survival; 
  run; 
 
 
 
 
  proc append base=sassy.SIMULATED_Surv5Yr data=SIMULATED_Surv5Yr&i 
force;   
  run; 
 
 
 %end; 
%mend; 
 
 
 
%DFS(1000); 
 
 
 
proc print data=sassy.SIMULATED_Surv5Yr; 
var lost survival newcensordt; 
run; 
proc means data=sassy.SIMULATED_Surv5Yr; 
title "5-Year Survival for Simulated Lost Patients (Delete 1 Follow- 
up)"; 
 var survival; 
run; 
 
 
proc means data=sassy.SIMULATED_Surv5Yr median; 
 var survival; 
run; 
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************************************************************************; 
 
 
**** checking how longer the period is between first lost & last visit for  
LOST patients; 
 
 
 
 
 
proc sort data=raw.continuous_status; 
by pid assessid; 
run; 
 
proc sort data=sassy.final; 
by pid; 
run; 
 
data first; 
 merge sassy.final(IN=final) raw.continuous_status 
(rename=(assessid=firstlost)); 
 by pid firstlost; 
  
 if final=1;  ** patients in our cohort only; 
 if lost=1;  ** keep lost patients only; 
 
 firstdate=nccncarestatdt; 
 
 keep pid firstlost firstdate; 
run; 
 
 
 
 
 
 
 
data last; 
 set raw.continuous_status(rename=(assessid=lastassess)  
where=(nccncarestatdt^=.)); 
 by pid lastassess; 
 
 if last.pid=1 & last.lastassess=1; 
 
 lastdate=nccncarestatdt; 
 
 keep pid lastassess lastdate; 
 
run; 
 
 
 
 
 
data period; 
45 
 
 merge first(IN=lostonly) last; 
 by pid; 
 
 if lostonly=1; 
 
 period=(lastdate-firstdate)/365.25; 
 assess_period=period*12; 
 
run;  
 
 
 
 
 
proc means data=period; 
var period assess_period; 
run; 
 
proc means data=period median; 
var period assess_period; 
run; 
 
 
 
*** Delete 1 follow-up period instead of 2, median=12months; 
 
 
 
 
****************************************************************************; 
 
 
 
 
 
 
 
 
ods graphics off; 
